Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dunconor LimitedfiledCriticalDunconor Limited
Priority to IES950207priorityCriticalpatent/IES64896B2/en
Publication of IES950207A2publicationCriticalpatent/IES950207A2/en
Publication of IES64896B2publicationCriticalpatent/IES64896B2/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
A process for preparing in essentially pure form the d-isomer of a compound of the formula I <CHEM 1> wherein X is chlorine and n is 0 or 1, or a pharmaceutically acceptable addition salt thereof, comprises reacting the dl-form of a compound formula I with a 3,5-disubstituted benzoic acid as resolving agent and, if desired, converting the compound thus obtained into a pharmaceutically acceptable acid addition salt thereof. These compounds have strong anti-histamine activity.
IES9502071995-03-231995-03-23Process for the resolution of racemic 3-(2-pyridyl)-3-phenyl-N,N-dimethylpropylamines
IES64896B2
(en)
Process for producing hydroxymethyl-(methylenecyclopentyl)-purines and -pyrimidines, their pharmaceutically acceptable salts and pharmaceutical compositions comprising same
Substituted cyclopropylamino-1,3,5-triazines, enantiomers, racemic mixtures or non-toxic, pharmaceutically acceptable acid addition salts thereof possessing pharmacological activity and process for the preparation thereof
Process for the preparation of the (-)-N-methyl-N-{4-(4- phenyl-4-acetylaminopiperidin-1-yl)-2-(3,4-dichlorophenyl) butyl}benzamide and its pharmaceutically acceptable salts